Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Elevance Health Inc.

Bernstein analyst Lance Wilkes maintained a Buy rating on Elevance Health yesterday and set a price target of $488.00. The company’s shares closed ...

Elevance Health (ELV) Gets a Buy from Bernstein

Elevra Lithium ( ($AU:ELV) ) just unveiled an announcement. Elevra Lithium has scheduled the release of its June 2026 Quarterly Activities Report f...

Elevra Lithium Sets Date for June Quarter Results Webcast

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Iovance Biotherapeutics (IOVA), Elevance Health (E...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Iovance Biotherapeutics (IOVA), Elevance Health (ELV) and InnovAge Holding (INNV)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 10x Genomics (TXG), Elevance Health (ELV) and John...

Analysts Have Conflicting Sentiments on These Healthcare Companies: 10x Genomics (TXG), Elevance Health (ELV) and Johnson & Johnson (JNJ)

Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on EasyJet (EJTTF) and Electrovaya (ELVA). EasyJet (EJTTF) In ...

Analysts Offer Insights on Industrial Goods Companies: EasyJet (OtherEJTTF) and Electrovaya (ELVA)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avita Medical (RCEL), Tenaya Therapeutics (TNYA) and...

Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Tenaya Therapeutics (TNYA) and Elevance Health (ELV)

Electrovaya stock rallied on Wednesday after the company announced a new partnership with Amazon.


Electrovaya Stock (ELVA) Soars on a New Amazon (AMZN) Battery Partnership

Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Kawasaki Kisen Kaisha (KAKKF) and Electrovay...

Analysts Offer Insights on Industrial Goods Companies: Kawasaki Kisen Kaisha (OtherKAKKF) and Electrovaya (ELVA)

TD Cowen analyst Ryan Langston maintained a Buy rating on Elevance Health today and set a price target of $465.00. According to TipRanks, Langston ...

TD Cowen Keeps Their Buy Rating on Elevance Health (ELV)

Elevra Lithium ( ($AU:ELV) ) has issued an update. Elevra Lithium Limited has notified the issuance of 2,160 unquoted performance rights under its ...

Elevra Lithium Boosts Employee Incentive Pool Ahead of June Quarter Production Update

In a report released today, from Macquarie maintained a Buy rating on Elevra Lithium, with a price target of A$14.50. Currently, the analyst consen...

Elevra Lithium (SYAXF) Receives a Buy from Macquarie

Elevra Lithium ( ($AU:ELV) ) just unveiled an announcement. Elevra Lithium Limited has notified the market of the issuance of 2,160 unquoted perfor...

Elevra Lithium Issues New Unquoted Performance Rights Under Incentive Plan

Elevra Lithium ( ($AU:ELV) ) has shared an announcement. Elevra Lithium Limited, listed on the ASX under the ticker ELV, operates in the lithium se...

Elevra Lithium Issues New Shares Following Option Conversions

Elevra Lithium ( ($AU:ELV) ) just unveiled an announcement. Elevra Lithium Limited has confirmed the lapse of 49,990 performance rights, identified...

Elevra Lithium Reports Lapse of Performance Rights

Elevra Lithium ( ($AU:ELV) ) has shared an update. Elevra Lithium Limited has notified the market of the issue of 5,276,387 unquoted options, exerc...

Elevra Lithium Issues Over 5.2 Million Unquoted Options

An update from Elevra Lithium ( ($AU:ELV) ) is now available. Morgan Stanley and its subsidiaries have notified Elevra Lithium that they have cease...

Morgan Stanley Ceases to Be Substantial Holder in Elevra Lithium

Elevra Lithium ( ($AU:ELV) ) has shared an update. Mitsubishi UFJ Financial Group has lodged a notice stating it has ceased to be a substantial hol...

Mitsubishi UFJ exits substantial holding in Elevra Lithium

Elevra Lithium ( ($AU:ELV) ) has provided an update. Elevra Lithium has broken ground on its fully funded North American Lithium Expansion Project,...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ELV	$378.67	+0.26%	623.98K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ELV	$378.67	+0.3%	623.98K
3
4
5
6

ELV

ELV

Get Elevance Health Inc. Data in Excel

Get Elevance Health Inc. Data in Excel